Anthea Pharma vs JYMed Peptide

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/antheapharma/jymedtech

Category	Anthea Pharma	JYMed Peptide
Listed site	both	cdmo
Summary	Anthea Pharma is an injectable CDMO in Hyderabad, India, offering development and manufacturing of vials, emulsions, lyophilized vials, and prefilled syringes. The company highlights aseptic fill and finish, terminal sterilization, lyophilization, and formulation and analytical development for clients.	Peptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site.
Services	Formulation Development CMC Analytical Development Lyophilization (Freeze Drying) Vial Filling Sterile Fill-Finish & Aseptic Manufacturing Prefilled Syringe (PFS) Filling Technology Transfer Process Development Quality Control Testing	Peptide Manufacturing API Synthesis & Manufacturing Process Development CMC Analytical Development Formulation Development Lyophilization (Freeze Drying) Cartridge Filling Prefilled Syringe (PFS) Filling Sterile Fill-Finish & Aseptic Manufacturing Secondary Packaging & Labeling Quality Control Testing CMC Regulatory Submission Support
Modalities	Data not yet provided.	Peptide
Indications	Data not yet provided.	Data not yet provided.
Locations	Hyderabad, Hyderabad, Telangana, India	Shenzhen headquarters, Shenzhen, Guangdong, China Shenzhen R&D Center, Shenzhen, Guangdong, China Shenzhen FDF manufacturing site, Shenzhen, Guangdong, China Hubei API manufacturing site, Hubei, China
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.